838 related articles for article (PubMed ID: 17481657)
1. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
Hansen SB; Taylor P
J Mol Biol; 2007 Jun; 369(4):895-901. PubMed ID: 17481657
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
Brejc K; van Dijk WJ; Klaassen RV; Schuurmans M; van Der Oost J; Smit AB; Sixma TK
Nature; 2001 May; 411(6835):269-76. PubMed ID: 11357122
[TBL] [Abstract][Full Text] [Related]
3. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
Xiao Y; Hammond PS; Mazurov AA; Yohannes D
J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
[TBL] [Abstract][Full Text] [Related]
4. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
Arias HR
Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
[TBL] [Abstract][Full Text] [Related]
5. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
Hansen SB; Sulzenbacher G; Huxford T; Marchot P; Taylor P; Bourne Y
EMBO J; 2005 Oct; 24(20):3635-46. PubMed ID: 16193063
[TBL] [Abstract][Full Text] [Related]
6. Determination of alpha-conotoxin binding modes on neuronal nicotinic acetylcholine receptors.
Dutertre S; Nicke A; Tyndall JD; Lewis RJ
J Mol Recognit; 2004; 17(4):339-47. PubMed ID: 15227641
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of Dalpha6 and Dalpha7 nicotinic acetylcholine receptor subunits from Drosophila: formation of a high-affinity alpha-bungarotoxin binding site revealed by expression of subunit chimeras.
Lansdell SJ; Millar NS
J Neurochem; 2004 Jul; 90(2):479-89. PubMed ID: 15228604
[TBL] [Abstract][Full Text] [Related]
8. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
Tsetlin V; Utkin Y; Kasheverov I
Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
[TBL] [Abstract][Full Text] [Related]
9. Generation of candidate ligands for nicotinic acetylcholine receptors via in situ click chemistry with a soluble acetylcholine binding protein template.
Grimster NP; Stump B; Fotsing JR; Weide T; Talley TT; Yamauchi JG; Nemecz Á; Kim C; Ho KY; Sharpless KB; Taylor P; Fokin VV
J Am Chem Soc; 2012 Apr; 134(15):6732-40. PubMed ID: 22394239
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.
Olsen JA; Ahring PK; Kastrup JS; Gajhede M; Balle T
J Biol Chem; 2014 Sep; 289(36):24911-21. PubMed ID: 24982426
[TBL] [Abstract][Full Text] [Related]
11. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
Arias HR
Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of a human neuronal nAChR extracellular domain in pentameric assembly: Ligand-bound α2 homopentamer.
Kouvatsos N; Giastas P; Chroni-Tzartou D; Poulopoulou C; Tzartos SJ
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9635-40. PubMed ID: 27493220
[TBL] [Abstract][Full Text] [Related]
13. Analysis of rare variations reveals roles of amino acid residues in the N-terminal extracellular domain of nicotinic acetylcholine receptor (nAChR) alpha6 subunit in the functional expression of human alpha6*-nAChRs.
Dash B; Li MD
Mol Brain; 2014 May; 7():35. PubMed ID: 24886653
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP.
Ulens C; Hogg RC; Celie PH; Bertrand D; Tsetlin V; Smit AB; Sixma TK
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3615-20. PubMed ID: 16505382
[TBL] [Abstract][Full Text] [Related]
15. Unorthodox Acetylcholine Binding Sites Formed by α5 and β3 Accessory Subunits in α4β2* Nicotinic Acetylcholine Receptors.
Jain A; Kuryatov A; Wang J; Kamenecka TM; Lindstrom J
J Biol Chem; 2016 Nov; 291(45):23452-23463. PubMed ID: 27645992
[TBL] [Abstract][Full Text] [Related]
16. AChBP-targeted alpha-conotoxin correlates distinct binding orientations with nAChR subtype selectivity.
Dutertre S; Ulens C; Büttner R; Fish A; van Elk R; Kendel Y; Hopping G; Alewood PF; Schroeder C; Nicke A; Smit AB; Sixma TK; Lewis RJ
EMBO J; 2007 Aug; 26(16):3858-67. PubMed ID: 17660751
[TBL] [Abstract][Full Text] [Related]
17. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor.
Brejc K; van Dijk WJ; Smit AB; Sixma TK
Novartis Found Symp; 2002; 245():22-9; discussion 29-32, 165-8. PubMed ID: 12027010
[TBL] [Abstract][Full Text] [Related]
18. Computational approaches to understand alpha-conotoxin interactions at neuronal nicotinic receptors.
Dutertre S; Lewis RJ
Eur J Biochem; 2004 Jun; 271(12):2327-34. PubMed ID: 15182348
[TBL] [Abstract][Full Text] [Related]
19. Physostigmine and galanthamine bind in the presence of agonist at the canonical and noncanonical subunit interfaces of a nicotinic acetylcholine receptor.
Hamouda AK; Kimm T; Cohen JB
J Neurosci; 2013 Jan; 33(2):485-94. PubMed ID: 23303929
[TBL] [Abstract][Full Text] [Related]
20. Differential Contribution of Subunit Interfaces to α9α10 Nicotinic Acetylcholine Receptor Function.
Boffi JC; Marcovich I; Gill-Thind JK; Corradi J; Collins T; Lipovsek MM; Moglie M; Plazas PV; Craig PO; Millar NS; Bouzat C; Elgoyhen AB
Mol Pharmacol; 2017 Mar; 91(3):250-262. PubMed ID: 28069778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
